跳至主要内容
临床试验/CTRI/2010/091/000015
CTRI/2010/091/000015尚未招募未知

In vitro DNA damage assessment as predictor of response to chemotherapy in acute myeloid leukemia.

Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-1100290 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of acute myeloid leukemia of either sex in the age ≤ 60 years who are willing for treatment.

排除标准

  • (1) Patients with aleukemic leukemia.
  • (2) Patients with AML M3 sub type.
  • (3) Patients with contraindication for chemotherapy.
  • (4) Patients not willing for the treatment.
  • (5) Patients not giving written consent for the study.

研究者

发起方
Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-110029

相似试验